Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Pseudoxanthoma Elasticum Research 2010 Conference

Monday, November 29, 2010 - Tuesday, November 30, 2010
North Bethesda Marriott , Bethesda, MD

The specific aims of this conference were to review the current status of basic and translational research on pseudoxanthoma elasticum (PXE), determine the most relevant biomarkers and clinical endpoints in preparation for clinical trials, and evaluate a number of hypothetical therapeutic interventions including vitamin K therapy and anti-angiogenesis therapies. Additionally, meeting participants reviewed the understanding of the clinical manifestations of PXE in order to come to consensus on diagnostic criteria. The results of the meeting will be used to plan for future research and translational applications.

Hung Tseng, Ph.D., (301) 496-0810,

Co-funding Institute(s):
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Office of Rare Diseases Research

From the National Center for Advancing Translational Sciences

From the National Institutes of Health

Connect with ORDR

See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.